Levothyroxine Sodium Tablet
Product Images NDC 71335-3116

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 71335-3116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)
Chemical structure of levothyroxine sodium showing two iodinated aromatic rings, a hydroxyl group, and an amino acid side chain with sodium carboxylate and water molecules.*
FDA Label Image

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)

FDA Label Image

Label (Lbl713353116)

Label (Lbl713353116)
Label for Levothyroxine Sodium Tablets, USP 150 mcg (0.15 mg), oral tablets by Bryant Ranch Prepack. The label shows NDC 71335-3116-1, package containing 30 tablets, repackaged by Bryant Ranch Prepack, Inc. in Burbank, CA, and manufactured by Lupin Limited. Storage instructions and caution about container seal are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.